Status:
COMPLETED
Biomarker Study of Blood Samples From Patients With Non-Small Cell Lung Cancer Treated With Carboplatin and Paclitaxel With or Without Bevacizumab
Lead Sponsor:
ECOG-ACRIN Cancer Research Group
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Lung Cancer
Eligibility:
All Genders
18-120 years
Brief Summary
RATIONALE: Studying samples of blood in the laboratory from patients undergoing treatment for non-small cell lung cancer may help doctors predict how patients will respond to treatment. PURPOSE: This...
Detailed Description
OBJECTIVES: Primary * To develop a serum proteomic classifier using matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry analysis of blood samples from patients with non-squa...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Available serum and plasma samples from patients with previously untreated locally advanced, metastatic, or recurrent non-squamous cell non-small cell lung cancer
- Enrolled on clinical trial ECOG-4599
- Treated with carboplatin and paclitaxel with or without bevacizumab
- PATIENT CHARACTERISTICS:
- Not specified
- PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Exclusion
Key Trial Info
Start Date :
March 14 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 14 2008
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT00898417
Start Date
March 14 2008
End Date
April 14 2008
Last Update
May 19 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.